Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies

American Journal of Human Genetics

Volumn 63, Issue 2, 1998, Pages 297-304

  Hodges, Maria ^a   Tissot, Catherine ^a   Howe, Kathy ^a   Grimwade, David ^a   Freemont, Paul S ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b Lab of Molec Struct and Function   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

CANCER INHIBITION; CELL COMPOSITION; CELL NUCLEUS INCLUSION BODY; CELL STRUCTURE; CELLULAR DISTRIBUTION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; VIRUS INFECTION;

EID: 0032231606     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301991     Document Type: Article

References (68)

1. Ahn MJ, Langenfeld J, Moasser MM, Rusch V, Dmitrovsky E (1995) Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors. Oncogene 11:2357-2364
2. Alcalay M, Tomassoni L, Colombo E, Stoldt S, Grignani F, Fagioli M, Szekely L, et al (1998) The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol 18:1084-1093
3. Ascoli CA, Maul GG (1991) Identification of a novel nuclear domain. J Cell Biol 112:785-795
4. Boddy MN, Duprez E, Borden KL, Freemont PS (1997) Surface residue mutations of the PML RING finger domain alter the formation of nuclear matrix-associated PML bodies. J Cell Sci 110:2197-2205
5. Boddy MN, Howe K, Etkin LD Solomon E, Freemont PS (1996) PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukemia. Oncogene 13: 971-982
6. Borden KL, Boddy MN, Lally J, O'Reilly NJ, Martin S, Howe K, Solomon E, et al (1995) The solution structure of the RING finger domain from the acute promyelocytic leukemia proto-oncoprotein PML. EMBO J 14:1532-1541
7. Borden KL, Campbell Dwyer EJ, Salvato MS (1998) An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol 72:758-766
8. Borden KL, Lally JM, Martin SR, O'Reilly NJ, Solomon E, Freemont PS (1996) In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc Natl Acad Sci USA 93:1601-1606
9. Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, et al (1997) A PML/RARα transgene initiates murine acute promyelocytic leukemia. Proc Nad Acad Sci USA 94:2551-2556
10. Cao T, Duprez E, Borden KL, Freemont PS, Etkin LD (1998) Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML. J Cell Sci 111: 1319-1329
11. Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954
12. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de The H (1998) Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72: 1043-1051
13. Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421
14. Desbois C, Rousset R, Bantignies F, Jalinot P (1996) Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science 273:951-953
15. Doucas V, Evans RM (1996) The PML nuclear compartment and cancer. Biochim Biophys Acta 1288:M25-M29
16. Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, Evans RM, Maul GG (1996) Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10:196-207
17. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM (1994) A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76:333-343
18. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, Kathoria M, Parkinson J (1998) The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110 and proteasome-dependent loss of several PML isoforms. J Virol 72:6581-6591
19. Everett RD, Maul GG (1994) HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J 13:5062-5069
20. Everett RD, Meredith M, Orr A, Cross A, Kathoria M, Parkinson J (1997) A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J 16: 1519-1530
21. Fagioli M, Alcalay M, Tomassoni L, Ferrucci PF, Mencarelli A, Riganelli D, Grignani F, et al (1998) Cooperation between the RING and B1-B2 and coiled coil domains of PML is necessary for its effect on cell survival. Oncogene 16: 2905-2913
22. Ferreira J, Paolella G, Ramos C, Lamond AI (1997) Spatial organization of large-scale chromatin domains in the nucleus: a magnified view of single chromosome territories. J Cell Biol 139:1597-1610
23. Gongora C, David G, Pintard L, Tissot C, Hua TD, Dejean A, Mechti N (1997) Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J Biol Chem 272:19457-19463
24. Grande MA, van der Kraan I, van Steensel B, Schul W, de The H, van der Voort HT, de Jong L, et al (1996) PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J Cell Biochem 63:280-291
25. Grignani F, de Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, et al (1998) Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukemia. Nature 391:815-818
26. Grignani F, Testa U, Rogaia D, Ferrucci PF, Samoggia P, Pinto A, Aldinucci D, et al (1996) Effects on differentiation by the promyelocytic leukemia PML/RARα protein depend on the fusion of the PML protein dimerization and RARα DNA binding domains. EMBO J 15:4949-4958
27. Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F, Walker H, et al (1997) Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia. Blood 90:4876-4885
28. Grimwade D, Solomon E (1997) Characterisation of the PML/ RARα rearrangement associated with t(15;17) acute promyelocytic leukemia. Curr Top Microbiol Immunol 220: 81-112
29. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ (1997) Altered myeloid development and acute leukemia in transgenic mice expressing PML/RARα under control of cathepsm G regulatory sequences. Blood 89:376-387
30. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A (1998) Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML/ and PLZF/RARα underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91:2634-2642
31. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP (1998) Distinct interactions of PML/RARα and PLZF/RARα with co-repressors determine differential responses to RA in APL. Nat Genet 18:126-135
32. He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, et al (1997) Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proc Natl Acad Sci USA 94:5302-5307
33. Ishov AM, Maul GG (1996) The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 134: 815-826
34. Ishov AM, Sternberg RM, Maul GG (1997) Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol 138:5-6
35. Jackson DA (1995) Nuclear organization: uniting replication foci chromatin domains and chromosome structure. Bioessays 17:587-591
36. Kamei H (1997) Cystine starvation induces reversible large-body formation from nuclear bodies in T24 cells. Exp Cell Res 237:207-216
37. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub MP, Durand B, Lanotte M, et al (1992) Structure localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J 11:629-642
38. Kelly C, Van Driel R, Wilkinson GW (1995) Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. J Gen Virol 76:2887-2893
39. Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thepot J, Juhlin L, et al (1995) The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315-1324
40. Koken MH, Reid A, Quignon F, Chelbi-Alix MK, Davies JM, Kabarowski JH, Zhu J, et al (1997) Leukemia-associated retinoic acid receptor alpha fusion partners PML and PLZF heterodimerize and colocalize to nuclear bodies. Proc Natl Acad Sci USA 94:10255-10260
41. Korioth F, Maul GG, Plachter B, Stamminger T, Frey J (1996) The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229: 155-158
42. Lamond AI, Earnshaw WC (1998) Structure and function in the nucleus. Science 280:547-553
43. LaMorte VJ, Dyck JA, Ochs RL, Evans RM (1998) Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc Natl Acad Sci USA 95: 4991-4996
44. Le XF, Vallian S, Mu ZM, Hung MC, Chang KS (1998) Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16:1839-1849
45. Le XF, Yang P, Chang KS (1996) Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene PML. J Biol Chem 271:130-135
46. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM (1998) Role of the histone deacetylase complex in acute promyelocytic leukemia. Nature 391:811-814
47. Matera AG, Frey MR (1998) Coiled bodies and gems: Janus or Gemini? Am J Hum Genet 63:317-321 (in this issue)
48. Maul GG, Yu E, Ishov AM, Epstein AL (1995) Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J Cell Biochem 59:498-513
49. Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS (1994) PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14:6858-67
50. Mu ZM, Le XF, Vallian S, Glassman AB, Chang KS (1997) Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis 18:2063-2069
51. Muller S, Matunis MJ, Dejean A (1998) Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17:61-70
52. Nickerson JA, Blencowe BJ, Penman S (1995) The architectural organization of nuclear metabolism. Int Rev Cytol 162A: 67-123
53. Onodera M, Kunisada T, Nishikawa S, Sakiyama Y, Matsumoto S, Nishikawa S (1995) Overexpression of retinoic acid receptor alpha suppresses myeloid cell differentiation at the promyelocyte stage. Oncogene 11:1291-1298
54. Pandolfi PP (1996) PML, PLZF, and NPM genes in the molecular pathogenesis of acute promyelocytic leukemia. Haematologica 81:472-482
55. Redner RL, Rush EA, Schesinger EW, Pollock SL, Watkins SC (1997) The t(5-17) APL fusion protein NPM-RAR does not alter PML localisation. Blood 90:1431
56. Saurin AJ, Borden KL, Boddy MN, Freemont PS (1996) Does this have a familiar RING? Trends Biochem Sci 21:208-214
57. Scheer U, Weisenberger D (1994) The nucleolus. Curr Opin Cell Biol 6:354-359
58. Shikama N, Lyon J, La Thangue NB (1997) The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol 7:230-236
59. Skinner PJ, Koshy BT, Cummings CJ, Klement IA, Helin K, Servadio A, Zoghbi HY, et al (1997) Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389:971-974 (erratum [1998] Nature 391:307)
60. Sternsdorf T, Grotzinger T, Jensen K, Will H (1997) Nuclear dots: actors on many stages. Immunobiology 198:307-331
61. Stuurman N, Floore A, Middelkoop E, van Driel R, de Jong L (1997) PML shuttles between nuclear bodies and the cytoplasm. Cell Mol Biol Lett 2:137-150
62. Takahashi M, Inaguma Y, Hiai H, Hirose F (1988) Developmentally regulated expression of a human "finger"-containing gene encoded by the 5′ half of the ret transforming gene. Mol Cell Biol 8:1853-1856
63. Terris B, Baldin V, Dubois S, Degott C, Flejou JF, Henin D, Dejean A (1995) PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res 55: 1590-1597
64. Tsai S, Collins SJ (1993) A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 90:7153-7157
65. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, et al (1998) Role of PML in cell growth and the retinoic acid pathway. Science 279:1547-1551
66. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, et al (1994) Retinoic acid regulates aberrant nuclear localization of PML/RARα in acute promyelocytic leukemia cells. Cell 76:345-356
67. Wells RA, Catzavelos C, Kamel-Reid S (1997) Fusion of retinoic acid receptor alpha to NuMA the nuclear mitotic apparatus protein by a variant translocation in acute promyelocytic leukemia. Nat Genet 17:109-113
68. Zhu J, Koken MH, Quignon F, Chelbi-Alix MK, Degos L, Wang ZY, Chen Z, et al (1997) Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci USA 94:3978-3983